The administration of the GnRH antagonist, cetrorelix, to oocyte donors simplifies oocyte donation

Human Reproduction

Volumn 18, Issue 6, 2003, Pages 1256-1258

  Thong, K J ^a   Yong, P Y ^b   Menezes, Q ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cetrorelix; Donor; FSH; Oocyte; Recombinant

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL VALERATE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; NAFARELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; AMPOULE; ARTICLE; CELL SYNCHRONIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DONOR; DOWN REGULATION; DRUG DOSE REGIMEN; DRUG EFFICACY; EARLY MENOPAUSE; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; GESTATION PERIOD; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; INFECTION; OOCYTE; OOCYTE DONATION; OVULATION INDUCTION; PREGNANCY RATE; PREMATURE OVARIAN FAILURE; PREMENOPAUSE; RECIPIENT; SPONTANEOUS ABORTION;

EID: 0038407757     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg271     Document Type: Article

References (14)

1. Albano, C., Smitz, J., Camus, M., Riethmuller-Winzen, H., Siebert-Weigel, M., Diedrich, K., Van Steirteghem, A.C. and Devroey, P. (1996) Hormonal profile during the follicular phase of in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (cetrorelix). Hum. Reprod., 11, 2114-2118.
2. Albano, C., Smitz, J., Camus, M., Riethmuller-Winzen, H., Van Steirteghem, A. and Devroey, P. (1997) Comparison of different doses of gonadotrophin antagonist cetrorelix during combined ovarian hyperstimulation. Fertil. Steril., 67, 917-922.
3. Felberbaum, R.E. and Diedrich, K. (1999) The use of the GnRH antagonists in assisted reproduction technologies. In Lunenfeld, B. (ed), GnRH Analogues. The State of the Art at the Millenium. The Parthenon Publishing Group, New York, pp. 47-63.
4. Hahn, D.W., McGuire, J.L., Vale, W.W. and Rivier, J. (1985) Reproductive/endocrine and anaphylactoid properties of an LHRH antagonist (ORF-12860). Life Sci., 37, 505-514.
5. Ludwig, M., Katalinic, A. and Diedrich, K. (2001a) Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch. Gynecol. Obstet., 265, 175-182.
6. Ludwig, M., Reithmullen-Winzen, H., Felberbaum, R.E., Olivennes, F., Albano, C., Devroey, P. and Diedrich, K. (2001b) Health of children born after controlled ovarian stimulation for in vitro fertilization using luteinising hormone-releasing hormone antagonist cetrorelix. Fertil. Steril., 75, 18-22.
7. Marcus, S.F. and Brinsden, P.R. (1999) Oocyte donation. In Brinsden, P.R. (ed.) A Textbook of In Vitro Fertilisation and Assisted Reproduction. The Parthenon Publishing Group Ltd, UK.
8. Olivennes, F., Mannaerts, B., Struijs, M., Bonduelle, M. and Devroey, P. (2001) Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: A preliminary report. Hum. Reprod., 16, 1588-1590.
9. Reissmann, T., Felberbaum, R., Diedrich, K., Engel, J., Comaru-Schally, A.M. and Schally, A.V. (1995) Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: An overview. Hum. Reprod., 10, 1974-1981.
10. Sauer, M.V. (2001) Defining the incidence of serious complications experienced by oocyte donors: A review of 1000 cases. Am. J. Obstet. Gynecol., 184, 277-278.
11. Sauer, M.V., Paulson, R.J. and Lobo, R.A. (1996) Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors. Int. J. Gynaecol. Obstet. 52, 259-262.
12. Sauer, M.V., Paulson, R.J. and Lobo, R.A. (1997) Comparing the clinical utility of GnRH antagonist to GnRH agonist in an oocyte donation program. Gynecol. Obstet. Invest., 43, 215-218.
13. Vankrieken, L., Van Der Horst, F.A.L., Castracane, V.D. et al. (1999) An international multicenter reference range study of normal menstrual cycles using IMMULITE reproductive hormone assays (abstract 322). Clin. Chem., 45 (Suppl. 6), A92.
14. Wikland, M., Bergh, C., Borg, K., Hillensjo, T., Howles, C.M., Knutsson, A., Nilsson, L. and Wood, M. (2001) A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI. Hum. Reprod., 16, 1676-1681.